The EGFR wild type and KRAS mutant Lewis lung carcinoma (LLC1)-bearing mouse is widely used as a model for testing the molecular mechanisms, anti-metastatic activity, and immunity of anticancer agents, although it is not an EGFR-mutant lung cancer model. This evidence concerns the gene KRAS and lung carcinoma.